WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017065493) ANTI-CD43 ANTIBODY AND USE THEREOF FOR CANCER TREATMENT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/065493    International Application No.:    PCT/KR2016/011428
Publication Date: 20.04.2017 International Filing Date: 12.10.2016
IPC:
A61K 39/395 (2006.01), A61K 45/06 (2006.01), G01N 33/50 (2006.01), G01N 33/574 (2006.01), A61K 39/00 (2006.01)
Applicants: APROGEN KIC INC. [KR/KR]; B2F,545, Dunchon-daero Jungwon-gu, Seongnam-si Gyeonggi-do 13215 (KR)
Inventors: HONG, Kwon Pyo; (KR).
YOON, Sangsoon; (KR).
KOUKOULAS, Irene; (AU).
BATORI, Vincent; (DE).
CRISTIANO, Briony; (US).
WILSON JR, David S; (US).
KOPSIDAS, George; (AU)
Agent: YOU ME PATENT AND LAW FIRM; 115 Teheran-ro Gangnam-gu, Seoul 06134 (KR)
Priority Data:
62/240,276 12.10.2015 US
2016901555 28.04.2016 AU
Title (EN) ANTI-CD43 ANTIBODY AND USE THEREOF FOR CANCER TREATMENT
(FR) ANTICORPS ANTI-CD43 ET LEUR UTILISATION POUR LE TRAITEMENT DU CANCER
(KO) 항-CD43 항체 및 이의 암 치료 용도
Abstract: front page image
(EN)The present invention relates to an antibody for cancer treatment and provides an anti-CD43 antibody which binds an extracellular region of CD43, an anti-cancer composition and a composition for inhibiting cancer stem cells comprising the anti-CD43 antibody as an active ingredient, and a method for screening a cancer stem cell inhibitor.
(FR)La présente invention concerne un anticorps pour le traitement du cancer et concerne un anticorps anti-CD43 qui se lie à une région extracellulaire de CD43, une composition anti-cancéreuse et une composition pour inhiber des cellules souches cancéreuses comprenant l'anticorps anti-CD43 comme principe actif, et un procédé de sélection d'un inhibiteur de cellules souches cancéreuses.
(KO)암 치료용 항체에 관한 것으로, CD43의 세포외 영역에 결합하는 항 -CD43 항체, 이를 유효성분으로 포함하는 항암 조성물, 암줄기세포 저해용 조성물, 및 암줄기세포 저해제의 스크리닝 방법이 제공된다.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Korean (KO)
Filing Language: Korean (KO)